Oxytocin antagonists with changes in the Asn5 position shed light on hormone-oxytocin receptor interactions

P. S. Hill, W. Y. Chan, Victor J Hruby

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Since oxytocin agonists and antagonists have different structure-activity relationships, we have investigated the stereostructural and stereoelectronic requirements of the Asn5 residue in oxytocin antagonists by the synthesis of four analogues of the potent, prolonged acting oxytocin antagonist [Pen1,D-Phe2,Thr4,Orn8]-oxytocin (I) in which Asn5 was replaced respectively with Thr (II), Leu5 (III), Asp5 (IV) and Tyr5 (V). These analogues had pA2 values in the antioxytocic in vitro rat uterine assay of 7.23 (I), 7.16 (II), 6.67 (III), 7.21 (IV), and 6.76 (IV), respectively. All were also found to be weakly potent in the in vivo anti-vasopressor assay in the rat. These studies demonstrate very different structural and stereoelectronic requirements for oxytocin agonists and antagonists when they interact with the oxytocin uterine receptor.

Original languageEnglish (US)
Pages (from-to)32-37
Number of pages6
JournalInternational Journal of Peptide and Protein Research
Volume38
Issue number1
StatePublished - 1991

Fingerprint

Oxytocin Receptors
Oxytocin
Hormones
Rats
Assays
Structure-Activity Relationship

ASJC Scopus subject areas

  • Biochemistry

Cite this

@article{35bf64addd42478eb1dc80f8bda1c095,
title = "Oxytocin antagonists with changes in the Asn5 position shed light on hormone-oxytocin receptor interactions",
abstract = "Since oxytocin agonists and antagonists have different structure-activity relationships, we have investigated the stereostructural and stereoelectronic requirements of the Asn5 residue in oxytocin antagonists by the synthesis of four analogues of the potent, prolonged acting oxytocin antagonist [Pen1,D-Phe2,Thr4,Orn8]-oxytocin (I) in which Asn5 was replaced respectively with Thr (II), Leu5 (III), Asp5 (IV) and Tyr5 (V). These analogues had pA2 values in the antioxytocic in vitro rat uterine assay of 7.23 (I), 7.16 (II), 6.67 (III), 7.21 (IV), and 6.76 (IV), respectively. All were also found to be weakly potent in the in vivo anti-vasopressor assay in the rat. These studies demonstrate very different structural and stereoelectronic requirements for oxytocin agonists and antagonists when they interact with the oxytocin uterine receptor.",
author = "Hill, {P. S.} and Chan, {W. Y.} and Hruby, {Victor J}",
year = "1991",
language = "English (US)",
volume = "38",
pages = "32--37",
journal = "International Journal of Peptide and Protein Research",
issn = "0367-8377",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Oxytocin antagonists with changes in the Asn5 position shed light on hormone-oxytocin receptor interactions

AU - Hill, P. S.

AU - Chan, W. Y.

AU - Hruby, Victor J

PY - 1991

Y1 - 1991

N2 - Since oxytocin agonists and antagonists have different structure-activity relationships, we have investigated the stereostructural and stereoelectronic requirements of the Asn5 residue in oxytocin antagonists by the synthesis of four analogues of the potent, prolonged acting oxytocin antagonist [Pen1,D-Phe2,Thr4,Orn8]-oxytocin (I) in which Asn5 was replaced respectively with Thr (II), Leu5 (III), Asp5 (IV) and Tyr5 (V). These analogues had pA2 values in the antioxytocic in vitro rat uterine assay of 7.23 (I), 7.16 (II), 6.67 (III), 7.21 (IV), and 6.76 (IV), respectively. All were also found to be weakly potent in the in vivo anti-vasopressor assay in the rat. These studies demonstrate very different structural and stereoelectronic requirements for oxytocin agonists and antagonists when they interact with the oxytocin uterine receptor.

AB - Since oxytocin agonists and antagonists have different structure-activity relationships, we have investigated the stereostructural and stereoelectronic requirements of the Asn5 residue in oxytocin antagonists by the synthesis of four analogues of the potent, prolonged acting oxytocin antagonist [Pen1,D-Phe2,Thr4,Orn8]-oxytocin (I) in which Asn5 was replaced respectively with Thr (II), Leu5 (III), Asp5 (IV) and Tyr5 (V). These analogues had pA2 values in the antioxytocic in vitro rat uterine assay of 7.23 (I), 7.16 (II), 6.67 (III), 7.21 (IV), and 6.76 (IV), respectively. All were also found to be weakly potent in the in vivo anti-vasopressor assay in the rat. These studies demonstrate very different structural and stereoelectronic requirements for oxytocin agonists and antagonists when they interact with the oxytocin uterine receptor.

UR - http://www.scopus.com/inward/record.url?scp=0025851710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025851710&partnerID=8YFLogxK

M3 - Article

C2 - 1657804

AN - SCOPUS:0025851710

VL - 38

SP - 32

EP - 37

JO - International Journal of Peptide and Protein Research

JF - International Journal of Peptide and Protein Research

SN - 0367-8377

IS - 1

ER -